HRP20120385T1 - Derivati 5-hidroksimetil-oksazolidin-2-ona - Google Patents
Derivati 5-hidroksimetil-oksazolidin-2-ona Download PDFInfo
- Publication number
- HRP20120385T1 HRP20120385T1 HRP20120385TT HRP20120385T HRP20120385T1 HR P20120385 T1 HRP20120385 T1 HR P20120385T1 HR P20120385T T HRP20120385T T HR P20120385TT HR P20120385 T HRP20120385 T HR P20120385T HR P20120385 T1 HRP20120385 T1 HR P20120385T1
- Authority
- HR
- Croatia
- Prior art keywords
- oxo
- fluoro
- compound
- oxazolidin
- phenoxymethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB2006054189 | 2006-11-10 | ||
| PCT/IB2007/054557 WO2008056335A1 (en) | 2006-11-10 | 2007-11-09 | 5-hydroxymethyl-oxazolidin-2-one derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20120385T1 true HRP20120385T1 (hr) | 2012-06-30 |
Family
ID=39170372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20120385TT HRP20120385T1 (hr) | 2006-11-10 | 2007-11-09 | Derivati 5-hidroksimetil-oksazolidin-2-ona |
Country Status (27)
| Country | Link |
|---|---|
| EP (1) | EP2086968B1 (OSRAM) |
| JP (2) | JP4484965B2 (OSRAM) |
| KR (1) | KR101118402B1 (OSRAM) |
| CN (1) | CN101535305B (OSRAM) |
| AR (1) | AR063788A1 (OSRAM) |
| AT (1) | ATE544764T1 (OSRAM) |
| AU (1) | AU2007318901B2 (OSRAM) |
| BR (1) | BRPI0718862B8 (OSRAM) |
| CA (1) | CA2668280C (OSRAM) |
| CL (1) | CL2007003232A1 (OSRAM) |
| CY (1) | CY1112696T1 (OSRAM) |
| DK (1) | DK2086968T3 (OSRAM) |
| ES (1) | ES2380388T3 (OSRAM) |
| HR (1) | HRP20120385T1 (OSRAM) |
| IL (1) | IL198645A (OSRAM) |
| MA (1) | MA30960B1 (OSRAM) |
| MX (1) | MX2009004764A (OSRAM) |
| MY (1) | MY148847A (OSRAM) |
| NO (1) | NO344727B1 (OSRAM) |
| NZ (1) | NZ577538A (OSRAM) |
| PL (1) | PL2086968T3 (OSRAM) |
| PT (1) | PT2086968E (OSRAM) |
| RU (1) | RU2453546C2 (OSRAM) |
| SI (1) | SI2086968T1 (OSRAM) |
| TW (1) | TWI374138B (OSRAM) |
| WO (1) | WO2008056335A1 (OSRAM) |
| ZA (1) | ZA200904028B (OSRAM) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003031443A1 (en) | 2001-10-04 | 2003-04-17 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety |
| ES2308171T3 (es) | 2003-04-30 | 2008-12-01 | Morphochem Aktiengesellschaft Fur Kombinatorische Chemie | Uso de antibioticos hibridos de oxazolidinona-quinolina para el tratamiento del antrax y de otras infecciones. |
| DE10340485B4 (de) | 2003-09-03 | 2015-05-13 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden |
| US8158797B2 (en) | 2003-12-18 | 2012-04-17 | Morphochem Aktiengesellschaft Fur Kombinatorische Chemie | Oxazolidinone-quinolone hybrid antibiotics |
| CA2549675C (en) † | 2003-12-18 | 2012-11-20 | Morphochem Aktiengesellschaft Fur Kombinatorische Chemie | Oxazolidinone-quinolone hybrid antibiotics |
| US8124623B2 (en) | 2006-11-10 | 2012-02-28 | Actelion Pharmaceuticals Ltd. | 5-hydroxymethyl-oxazolidin-2-one-derivatives and their uses as antibacterials |
| RU2527769C2 (ru) * | 2008-05-09 | 2014-09-10 | Актелион Фармасьютиклз Лтд | Производные 5-гидроксиметилоксазолидин-2-она для лечения бактериальных кишечных заболеваний |
| JP6030146B2 (ja) * | 2011-11-08 | 2016-11-24 | アクテリオン ファーマシューティカルズ リミテッドＡｃｔｅｌｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ | ２−オキソ−オキサゾリジン−３，５−ジイル抗生物質誘導体 |
| CN105246476B (zh) | 2013-05-28 | 2019-11-15 | 莫弗凯姆联合化学股份公司 | 含噁唑烷酮-喹诺酮的联合疗法在治疗细菌感染中的应用 |
| MX371037B (es) | 2013-05-28 | 2020-01-14 | Morphochem Aktiengesellschaft Fuer Komb Chemie | Antibacterianos híbridos de oxazolidinona-quinolona para el tratamiento parenteral o profilaxis de enfermedades bacterianas. |
| WO2016079757A2 (en) * | 2014-11-19 | 2016-05-26 | Symed Labs Limited | Novel processes for preparing 5-hydroxymethyl-oxazolidin-2-one derivatives |
| WO2017146246A1 (ja) | 2016-02-26 | 2017-08-31 | 大塚製薬株式会社 | ピペリジン誘導体 |
| US10087171B2 (en) | 2016-12-19 | 2018-10-02 | Actelion Pharmaceuticals Ltd | Crystalline forms of cadazolid |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1156597A3 (ru) * | 1982-04-28 | 1985-05-15 | Е.И.Дюпон Де Немур Энд Компани (Фирма) | Способ получени производных 3-( @ -алкилсульфонилфенил)оксазолидинона или их фармацевтически приемлемых кислотно-аддитивных солей |
| US4461773A (en) * | 1982-09-15 | 1984-07-24 | E. I. Dupont De Nemours And Company | P-Oxooxazolidinylbenzene compounds as antibacterial agents |
| US6608081B2 (en) * | 1999-08-12 | 2003-08-19 | Ortho-Mcneil Pharmaceutical, Inc. | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods |
| US6413981B1 (en) * | 1999-08-12 | 2002-07-02 | Ortho-Mcneil Pharamceutical, Inc. | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods |
| ATE319710T1 (de) * | 2000-12-21 | 2006-03-15 | Pharmacia & Upjohn Co Llc | Antimikrobielle chinolonderivate und ihre verwendung zur behandlung bakterieller infektionen |
| US6951863B2 (en) * | 2001-02-07 | 2005-10-04 | Ortho-Mcneil Pharmaceutical, Inc. | Pyridoarylphenly oxazolidinone antibacterials, and related compositions and methods |
| WO2003031443A1 (en) * | 2001-10-04 | 2003-04-17 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety |
| ZA200509147B (en) * | 2003-04-30 | 2007-03-28 | Morphochem Ag | Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections |
| ES2308171T3 (es) * | 2003-04-30 | 2008-12-01 | Morphochem Aktiengesellschaft Fur Kombinatorische Chemie | Uso de antibioticos hibridos de oxazolidinona-quinolina para el tratamiento del antrax y de otras infecciones. |
| CA2549675C (en) * | 2003-12-18 | 2012-11-20 | Morphochem Aktiengesellschaft Fur Kombinatorische Chemie | Oxazolidinone-quinolone hybrid antibiotics |
| KR100854211B1 (ko) * | 2003-12-18 | 2008-08-26 | 동아제약주식회사 | 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물 |
-
2007
- 2007-11-09 AT AT07827038T patent/ATE544764T1/de active
- 2007-11-09 CA CA2668280A patent/CA2668280C/en active Active
- 2007-11-09 BR BRPI0718862A patent/BRPI0718862B8/pt not_active IP Right Cessation
- 2007-11-09 NZ NZ577538A patent/NZ577538A/en not_active IP Right Cessation
- 2007-11-09 HR HRP20120385TT patent/HRP20120385T1/hr unknown
- 2007-11-09 PL PL07827038T patent/PL2086968T3/pl unknown
- 2007-11-09 EP EP07827038A patent/EP2086968B1/en active Active
- 2007-11-09 AU AU2007318901A patent/AU2007318901B2/en not_active Ceased
- 2007-11-09 CN CN2007800418985A patent/CN101535305B/zh not_active Expired - Fee Related
- 2007-11-09 DK DK07827038.6T patent/DK2086968T3/da active
- 2007-11-09 TW TW096142564A patent/TWI374138B/zh not_active IP Right Cessation
- 2007-11-09 RU RU2009121812/04A patent/RU2453546C2/ru active
- 2007-11-09 JP JP2009535864A patent/JP4484965B2/ja not_active Expired - Fee Related
- 2007-11-09 CL CL200703232A patent/CL2007003232A1/es unknown
- 2007-11-09 KR KR1020097010924A patent/KR101118402B1/ko not_active Expired - Fee Related
- 2007-11-09 WO PCT/IB2007/054557 patent/WO2008056335A1/en not_active Ceased
- 2007-11-09 ES ES07827038T patent/ES2380388T3/es active Active
- 2007-11-09 PT PT07827038T patent/PT2086968E/pt unknown
- 2007-11-09 MX MX2009004764A patent/MX2009004764A/es active IP Right Grant
- 2007-11-09 MY MYPI20091893A patent/MY148847A/en unknown
- 2007-11-09 SI SI200730902T patent/SI2086968T1/sl unknown
- 2007-11-12 AR ARP070105031A patent/AR063788A1/es active IP Right Grant
-
2009
- 2009-05-07 IL IL198645A patent/IL198645A/en active IP Right Grant
- 2009-06-01 MA MA31939A patent/MA30960B1/fr unknown
- 2009-06-09 ZA ZA200904028A patent/ZA200904028B/xx unknown
- 2009-06-09 NO NO20092209A patent/NO344727B1/no unknown
-
2010
- 2010-01-27 JP JP2010016076A patent/JP5490553B2/ja not_active Expired - Fee Related
-
2012
- 2012-04-24 CY CY20121100383T patent/CY1112696T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2009121812A (ru) | Производные 5-гидроксиметилоксазолидин-2-она | |
| JP4805139B2 (ja) | 炭疽および他の感染を治療するためのオキサゾリジノン‐キノリンハイブリッド抗生物質の使用 | |
| JP2010132677A5 (OSRAM) | ||
| HRP20160273T1 (hr) | Derivati pirazolokinolina kao inhibitori pde9 | |
| JP2013511486A5 (OSRAM) | ||
| SI2895174T1 (en) | The prodrugs of the amino quinazoline kinase inhibitor | |
| KR20040055781A (ko) | 이원적 작용 항생제 | |
| JP2014532754A5 (OSRAM) | ||
| ME02355B (me) | Derivati 2-0ks0-1-pirolidinil imidazotiadiazola | |
| US20190105367A1 (en) | Antimicrobial 4-oxoquinolizines | |
| JPH01316321A (ja) | ギラーゼ抑制因子の筋肉注射剤 | |
| HRP20120791T1 (hr) | Derivati 5-hidroksimetil-oksazolidin-2-ona za lijeäśenje bakterijskih bolesti crijeva | |
| Bryskier | Fluoroquinolones | |
| NZ596616A (en) | Aminopyrazole triazolothiadiazole inhibitors of c-met protien kinase | |
| US20080300403A1 (en) | Method for Production of Quinolone-Containing Lyophilized Preparation | |
| JP2016510749A5 (OSRAM) | ||
| JPS63188626A (ja) | ピリドンカルボン酸の可溶化方法 | |
| EA200970537A1 (ru) | Антибактериальные производные хинолина | |
| Arjona et al. | Nemonoxacin | |
| EP1219618A1 (en) | Quinolinecarboxylic acid derivative or its salt | |
| TW200732334A (en) | A 4-oxo-1-(3-substituted phenyl)-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitor and a method of preparing same | |
| Petersen | Quinolone antibiotics: the development of moxifloxacin | |
| JP2006232842A5 (OSRAM) | ||
| JPH06166623A (ja) | 抗菌性組成物 | |
| KR930021633A (ko) | 항균 활성을 갖는 피리돈카르복시산의 신규한 아제티딘 유도체 |